Analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a report issued on Saturday. The brokerage set a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Stock Performance
Shares of BTX opened at $0.58 on Friday. Brooklyn ImmunoTherapeutics has a one year low of $0.17 and a one year high of $10.10. The stock has a market capitalization of $34.12 million, a price-to-earnings ratio of -0.26 and a beta of 4.61. The stock has a 50 day moving average price of $0.39 and a 200 day moving average price of $1.08.
Brooklyn ImmunoTherapeutics Company Profile
Recommended Stories
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- What is a Stock Market Index and How Do You Use Them?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Pros And Cons Of Monthly Dividend Stocks
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Do ETFs Pay Dividends? What You Need to Know
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.